BIOMEX

We look back on our incredible experience at #ISSCR 2024 in Hamburg! 🙌 It was truly a great experience to be part of such a lively event alongside other companies in stem cell research. Our BIOMEX team had a fantastic time at the conference, engaging in stimulating discussions and making valuable contacts around our latest innovation, extracellular matrix (ECM) from human tissue cells. We were thrilled by the large turnout at our booth, where visitors showed great interest in our human-derived #ECM. We sincerely thank all those who visited us, interacted with us and explored how our human-tissue derived ECM could fulfill their research needs. Our special thanks to Dr. Manish Kumar, PhD and Dr. Djeda Belharazem for their expertise and dedication throughout the event. 🤝 If you missed us at ISSCR this year, feel free to get in touch with us via email at 👉 manish.kumar@biomex.de. We look forward to continuing these conversations and are excited for our next opportunity to meet at upcoming conferences. Thank you for this remarkable experience and we look forward to continuing to push the boundaries of stem cell and ECM research together! 🚀 #ISSCR #ISSCR2024 #BIOMEX #ECM #LifeScience #StemCells #Research #Innovation #Networking

Are you currently using synthetic or animal-derived ECM in human cancer and regenerative medical research and struggling with species specificity? Then we have exciting news for you! Visit us in Hamburg from July 10-13, where BIOMEX will be presenting our latest innovation, the Human Extracellular Matrix (ECM), in Hall H, booth #701. Curious? Our colleague, Dr. Manish Kumar, provides more information about our latest innovation in the video. Meet our colleagues Dr. Djeda Belharazem and Dr. Manish Kumar at ISSCR 2024 and discussing how BIOMEX can help you with your research projects. If you would like to make an appointment, make sure you register now before places fill up. 👉 https://rb.gy/wmcp45 #BIOMEX #ISSCR2024 #LifeSciences #Innovation #EmpoweringScientists

We are excited to share our experience from the Sample Management Symposium in Frankfurt, Germany, which took place last week. This year’s symposium, themed “Sample Management, Challenges and Solutions,” provided a unique opportunity to learn about the latest advancements in sample management and how they are revolutionizing the fields of pharma, biotech, and academia. BIOMEX participated in this important event because we believe that the exchange of insights about the latest developments in sample management is crucial for the growth of both BIOMEX and other industries present at the symposium. This mutual exchange is beneficial for everyone involved. By engaging with other experts, we can all stay at the forefront of innovation and ensure that our solutions continue to meet the highest standards, ultimately driving forward our collective knowledge and capabilities. Our colleagues Wilhelm Bauer and Alexander Wilhelm attended, eager to exchange insights and network with fellow industry experts. At the symposium, BIOMEX had the opportunity to listen to enlightening discussions led by industry leaders such as from BASF, BioNTech and UCB Pharma. The event offered great opportunities to connect with other industries, enhancing our understanding and collaborations within the field of sample management. Looking forward to more inspiring and productive events in the future! Meanwhile, discover how BIOMEX's cutting-edge biobank services and software can revolutionize your sample management processes. Have questions or want to learn more? Reach out to our Sales Team 👉 sales@biomex.de.   #SampleManagementSymposium #EmpoweringScientists #Pharma #Biotech #Academia #Frankfurt2024

BIOMEX at ISSCR 2024 in Hamburg! 🤝 We are thrilled to announce that BIOMEX will be attending the ISSCR 2024 from July 10th to July 13th in Hamburg. BIOMEX is a distinguished life science and diagnostic company, renowned for providing high-quality human biospecimens, human primary cells, PBMCs, stem cells, cell culture media, tissue microarrays, and our FFPE biorepository.   Discover our latest innovation, the Human Extracellular Matrix (ECM), which will be showcased at the event:   ✔️BIOMEX's Human ECM offers superior performance and physiological relevance, significantly enhancing research outcomes. ✔️This species-specific product offers significant advantages over synthetic and animal-derived ECM in life science research due to its biological compatibility, functional relevance, ethical considerations, and regulatory acceptance. ✔️These benefits position human ECM as invaluable for advancing biomedical research and developing innovative therapies that closely mimic natural human tissues for personalized medicine. ✔️ Our ECM ensures consistency and reproducibility in experimental results, providing scientists a reliable tool to advance research. We are committed to empowering scientists and fostering breakthroughs in life science. For more information and insights, you can meet our colleagues, Dr. Djeda Belharazem and Dr. Manish Kumar, PhD, who will be available at Hall H, Booth #701. They will provide detailed information about our solutions and answer your questions. 👉 Book your appointment now for the conference from July 10th to 12th to learn more about ECM: https://rb.gy/wmcp45 Don’t miss this opportunity to connect with us, explore how we can support your research endeavors. We are looking forward to meeting you there! #BIOMEX #ISSCR #ISSCR2024 #EmpoweringScientists #JoinOurJourney #HamburgEvent

The countdown is on, and we are ready for the #ADLM, which takes place from July 28th to August 1st in Chicago. 🤝Meet our colleagues Joanna Raygoza, Mukesh Mani Tripathi, Ph.D and our general manager Oliver Bosnjak at booth number #4517. They'll be ready to discuss and provide insights into the services and products of #BIOMEX. BIOMEX as the leading European Provider of Human Biospecimens and a CRO for Diagnostic Studies in Europe, is specialized in delivering comprehensive services for your IVD compliance. Are you attending the ADLM? If so, we'd love to meet you! Let's connect and discuss how BIOMEX can support your needs. #lifesciences #BIOMEX #diagnostics #ADLM

Small gestures, big impact! At the beginning of this year, we started to surprise our colleagues with a thoughtful gift every month. From ginger sweets to the iconic Heidelberg student kiss for Valentine's Day, an Easter chocolate bunny, to cress for planting. This month, while enjoying the wonderful summer weather, we're continuing this tradition. This month, we're gifting sunscreen to ensure that our colleagues stay protected and comfortable during their lunch break outdoors. ☀️🌻 What thoughtful gestures have you experienced in your workplace that made a lasting impression? Share your experience below. Let's continue to spread kindness and positivity in the workplace and beyond. #BIOMEX #EmpoweringScientist #JoinOurJourney

Exciting Announcement from BIOMEX: Advancing Neurological Research! We're thrilled to announce our latest initiative aimed at propelling neurological research forward. At BIOMEX, we recognize the critical need for diverse and readily available biospecimen, especially in fields like Multiple Sclerosis (MS) and Alzheimer's Disease (AD). That's why we've proactively established a robust network of physicians and neurologists dedicated to sourcing fresh biospecimens to support vital research and longitudinal studies. Why Partner with BIOMEX? - Unprecedented Access: Gain access to a wide range of fresh biospecimen from MS and AD patients, allowing for comprehensive research and analysis. - Collaboration: Join forces with a community of dedicated professionals who share your passion for advancing neurological research. - Tailored Support: Benefit from personalized support and guidance from our experienced team, ensuring seamless procurement and delivery of biospecimens for your research projects. - IRB Approval and Informed Consents: BIOMEX has IRB approval and all the required informed consents, ensuring ethical and compliant sourcing of biospecimen. - Impactful Research: By participating in our network, you'll be contributing directly to groundbreaking research efforts aimed at unraveling the mysteries of MS and AD, ultimately leading to improved diagnostics and treatments. Don't miss this opportunity to collaborate with leading professionals. Contact us now to learn more and start your journey with BIOMEX! Link down below: https://shorturl.at/adjY5 #NeurologicalResearch #MS #Alzheimers #Biospecimens #ResearchPartnership #EmpoweringScientists

Did you know? Human Derived Extra Cellular Matrix (ECM) has the potential to revolutionize cell culture and tissue engineering, providing more biocompatible and physiologically relevant solutions. Our team at BIOMEX is at the forefront of this innovative technology, leveraging human-derived matrices to enhance cell adhesion, proliferation, and differentiation.   Advantages of Human Derived Extra Cellular Matrix (ECM): 1. Enhanced Biocompatibility: Closer resemblance to human tissue composition. 2. Reduced Immunogenicity: Lower risk of inaccurate immune responses compared to animal-derived alternatives. 3. Ethical Considerations: Aligning with principles of animal welfare and ethical research practices. 4. Consistency and Reproducibility: Improved reliability and reproducibility in experimental results. Are you interested in learning more about this topic? Feel free to schedule a meeting with one of our experienced colleagues. Link down below: https://shorturl.at/adjY5   #BiomedicalResearch #TissueEngineering #OrganoidResearch #HumanMatrix #HumanECM #Innovation #ResearchAdvancements #Organoids #CellCulture

Today, May 28, is World Blood Cancer Day. Every 27 seconds, someone worldwide is diagnosed with blood cancer. Many of these patients can’t survive without a life-saving stem cell donation. That’s why we want to ask you to get registered as a stem cell donor. It’s not difficult at all. And in the best-case scenario, you can save someone's life. We at BIOMEX are also proud to contribute to the fight against blood cancer by supporting further studies on this disease and potential therapies. We offer a diverse range of human samples, including isolated bone marrow cells from cancer patients, leukopaks, CD34+ cells, and tissue-derived human primary cells. Whether it’s human primary cells or circulating blood cells, we’ve got you covered! #BIOMEX#EmpoweringScientists#JoinOurJourney#WorldBloodCancerDay

Today is clinical trials day, and we celebrate the dedication, innovation and collaboration of all those involved in clinical research. We at BIOMEX support our customers’ needs as a contract research organization (CRO) to perform in vitro diagnostic studies – from development to the post-market phase. Our clinical trial portfolio includes clinical performance evaluations for PCR, rapid tests and immunoassays, useability studies (laymen and PoC/NPT) under European IVDR, Australian TGA or WHO regulations. What sets us apart from the competition is the study system we can offer. With our own donation centers, lab facilities, Europe’s largest commercial inventory of human biospecimens and 130 experts to serve you. How can our experts assist you? Try us – today! BIOMEX#EmpoweringScientists#JoinOurJourney#ClinicalTrialsDay